Related Experiment Video
Updated: Mar 15, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Managing Hyperkalemia: Stepping Into a New Frontier
Antony Q Pham1,2, Jessica Sexton1, Dexter Wimer1
11 Arnold and Marie Schwartz College of Pharmacy and Health Sciences, LIU Pharmacy, Brooklyn, NY, USA.
Abstract:
Maintaining potassium balance in the body is essential for cellular function. Even a slight increase in normal serum potassium levels (3.5-5.0 mEq/L) can interfere with metabolism, electrical action potentials, and cellular processes. Hyperkalemia is commonly seen in patients with chronic kidney disease (CKD) and in patients on renin-angiotensin-aldosterone system (RAAS) inhibitors. Sodium polystyrene sulfonate (SPS), diuretics, and hemodialysis are currently available methods for removing potassium from the body; however, these options have their limitations. Patiromer (Veltassa) and sodium zirconium cyclosilicate are 2 new therapeutic options that can potentially lead a new frontier in the management of hyperkalemia. This article will review these novel treatments.
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Antihypertensive Drugs: Potassium-Sparing Diuretics
Chronic Kidney Disease IV: Nursing Management
Dysrhythmias VI: Management of Dysrhythmias
Chronic Kidney Disease III: Interprofessional Care

